Applies to botulism antitoxin: parenteral for injection for iv use.
Side effects include:
Headache, nausea, pruritus, urticaria, fever, rash, chills, edema.
For Healthcare Professionals
Applies to botulism antitoxin: injectable solution.
Hypersensitivity
Uncommon (0.1% to 1%): Serum sickness
Frequency not reported: Hypersensitivity reactions
Postmarketing reports: Anaphylactic shock[Ref]
Other
Common (1% to 10%): Pyrexia, chills, edema
Uncommon (0.1% to 1%): Feeling jittery, chest discomfort
Frequency not reported: Infusion reactions[Ref]
Cardiovascular
Uncommon (0.1% to 1%): Blood pressure increased
Uncommon (0.1% to 1%): Hemodynamic instability (bradycardia, tachycardia, and asystole during administration), hypotension[Ref]
Hematologic
Uncommon (0.1% to 1%): White blood cell count increased[Ref]
Dermatologic
Common (1% to 10%): Pruritus, urticaria, rash
Uncommon (0.1% to 1%): Hyperhidrosis, erythema
Postmarketing reports: Angioedema[Ref]
Gastrointestinal
Common (1% to 10%): Nausea, throat discomfort[Ref]
Psychiatric
Uncommon (0.1% to 1%): Agitation, anxiety[Ref]
Respiratory
Uncommon (0.1% to 1%): Bronchospasm[Ref]
Genitourinary
Uncommon (0.1% to 1%): Urinary retention[Ref]
Nervous system
Common (1% to 10%): Headache[Ref]